<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName A++V2.4.dtd?>
  <?SourceDTD.Version 2.4?>
  <?ConverterInfo.XSLTName springer2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Neuroimmune Pharmacol</journal-id>
      <journal-title-group>
        <journal-title>Journal of Neuroimmune Pharmacology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1557-1890</issn>
      <issn pub-type="epub">1557-1904</issn>
      <publisher>
        <publisher-name>Springer US</publisher-name>
        <publisher-loc>Boston</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3111880</article-id>
      <article-id pub-id-type="pmid">20617464</article-id>
      <article-id pub-id-type="publisher-id">9228</article-id>
      <article-id pub-id-type="doi">10.1007/s11481-010-9228-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>CXCL12-Mediated Regulation of ANP32A/Lanp, A Component of the Inhibitor of Histone Acetyl Transferase (INHAT) Complex, in Cortical Neurons</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>Muhammad Z.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vaidya</surname>
            <given-names>Avinash</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Meucci</surname>
            <given-names>Olimpia</given-names>
          </name>
          <address>
            <phone>+1-215-7622597</phone>
            <fax>+1-215-7622299</fax>
            <email>omeucci@drexelmed.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 N. 15th Street, Philadelphia, PA 19102 USA </aff>
        <aff id="Aff2"><label>2</label>Department of Microbiology and Immunology, Drexel University College of Medicine, 245 N. 15th Street, Philadelphia, PA 19102 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>7</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>9</day>
        <month>7</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <volume>6</volume>
      <issue>1</issue>
      <fpage>163</fpage>
      <lpage>170</lpage>
      <history>
        <date date-type="received">
          <day>8</day>
          <month>3</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>6</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2010</copyright-statement>
      </permissions>
      <abstract id="Abs1">
        <p>The chemokine receptor CXCR4 and its endogenous ligand, CXCL12, are involved in development and homeostasis of the central nervous system and in the neuropathology of various neuroinflammatory/infectious disorders, including neuroAIDS. Our previous studies have shown that CXCR4 regulates cell cycle proteins that affect neuronal survival, such as the retinoblastoma protein, Rb. These studies also suggested that Rb-mediated gene repression might be involved in the neuronal protection against NMDA exitotoxicity conferred by stimulation of the CXCL12/CXCR4 axis. In order to further test this hypothesis, we focused on the potential interaction of Rb with another protein implicated in regulation of gene expression, leucine-rich acidic nuclear protein (Lanp), also known as ANP32A/pp32/PHAP1. Lanp is a critical member of the protein complex inhibitor of histone acetyl transferase (INHAT), which prevents histone tail's acetylation, thus leading to transcriptional repression. Our data show that, in primary rat cortical neurons cultured for up to 30&#xA0;days, Lanp is predominantly localized into the nucleus throughout the culture period, in line with in vivo evidence. Moreover, co-immunoprecipitation experiments show that endogenous Lanp interacts with Rb in neurons. Stimulation of CXCR4 by its endogenous ligand, CXCL12, increased Lanp protein levels in these neurons. Importantly, the effect of CXCL12 was preserved after exposure of neurons to NMDA. Finally, overexpression of exogenous Lanp in the neurons protects them from excitotoxicity. Overall, these findings suggest that Lanp can interact with Rb in both young and mature neurons and is implicated in the regulation of neuronal survival by CXCL12/CXCR4.</p>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1007/s11481-010-9228-5) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Rb</kwd>
        <kwd>CXCL12</kwd>
        <kwd>cell survival</kwd>
        <kwd>histone</kwd>
        <kwd>chemokine</kwd>
        <kwd>brain</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media, LLC 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p>The chemokine receptor CXCR4 and its endogenous ligand CXCL12 are expressed constitutively in the central nervous system (CNS) during development and adulthood and play important roles in physiology and pathology (Li and Ransohoff <xref ref-type="bibr" rid="CR17">2008</xref>). The CXCL12/CXCR4 axis has been implicated in important neuronal functions, such as modulation of neurotransmission, differentiation, and survival (Guyon and Nahon <xref ref-type="bibr" rid="CR8">2007</xref>; Li and Ransohoff <xref ref-type="bibr" rid="CR17">2008</xref>). Stimulation of CXCR4 by its natural ligand CXCL12 activates different signaling pathways in neurons (Li and Ransohoff <xref ref-type="bibr" rid="CR17">2008</xref>). Previous studies from our group have shown that CXCR4 also controls specific cell cycle regulators such as p53 and the cdk-Rb-E2F pathway in postmitotic neurons (Khan et al. <xref ref-type="bibr" rid="CR13">2005</xref>; Shimizu et al. <xref ref-type="bibr" rid="CR32">2007</xref>; Khan et al. <xref ref-type="bibr" rid="CR14">2008</xref>). These proteins may be involved in transcriptional regulation of specific sets of genes that affect the survival of postmitotic neurons independently of their role in cell cycle (Becker and Bonni <xref ref-type="bibr" rid="CR4">2004</xref>). In line with this, our findings indicate that CXCR4 positively regulates Rb and this controls the expression of E2F1 pro-apoptotic targets in neurons, thus resulting in neuroprotection (Khan et al. <xref ref-type="bibr" rid="CR11">2003</xref>; Shimizu et al. <xref ref-type="bibr" rid="CR32">2007</xref>; Khan et al. <xref ref-type="bibr" rid="CR14">2008</xref>). Interestingly, non-physiological ligands of CXCR4 that induce abnormal stimulation of CXCR4, such as the HIV-1 envelope protein gp120<sub>IIIB</sub>, are unable to stimulate Rb function and induce neurotoxicity via E2F-dependent pathways (Shimizu et al. <xref ref-type="bibr" rid="CR32">2007</xref>; Bachis et al. <xref ref-type="bibr" rid="CR2">2009</xref>). This further supports the role of Rb in neuroprotection and highlights the importance of proper function of the CXCL12/CXCR4 axis in the CNS.</p>
      <p>Rb is able to bind more than 100 different proteins, some of which directly or indirectly control cell fate (Morris and Dyson <xref ref-type="bibr" rid="CR22">2001</xref>). These interactions determine the various specific roles of Rb in a cell. Rb mostly acts as a gene suppressor and interacts with well-known transcription factors (e.g., E2F1), as well as enzymes regulating the post-translational modifications of histones (Macaluso et al. <xref ref-type="bibr" rid="CR18">2006</xref>). These chromatin modifications favor chromatin condensation, thus inhibiting gene expression by limiting access of transcription complexes to the DNA. Among the Rb-interacting proteins that regulate transcriptional activity, ANP32a/Lanp (also known as pp32, PHAP1, I1PP2A; henceforth referred to as Lanp in this paper) is also found in neurons (Matsuoka et al. <xref ref-type="bibr" rid="CR21">1994</xref>; Adegbola and Pasternack <xref ref-type="bibr" rid="CR1">2005</xref>). It belongs to a family of leucine-rich repeats-containing proteins (Matilla and Radrizzani <xref ref-type="bibr" rid="CR19">2005</xref>). Lanp is an integral component of the inhibitor of histone acetyl transferase complex (INHAT), which blocks transcription by masking N-terminal histone tails from the activity of histone acetyl transferases or through interaction with histone deacetylases (Seo et al. <xref ref-type="bibr" rid="CR30">2001</xref>; Seo et al. <xref ref-type="bibr" rid="CR31">2002</xref>). Recent studies indicate that, through its INHAT activity, Lanp is involved in both physiological and pathological processes in the CNS (Matilla and Radrizzani <xref ref-type="bibr" rid="CR19">2005</xref>). One example is its ability to regulate expression of neurofilament genes in neurons, which affects neuronal differentiation (Kular et al. <xref ref-type="bibr" rid="CR16">2009</xref>). Furthermore, alterations of Lanp functions have been implicated in spinocerebellar ataxia type 1 (SCA1) and Alzheimer's disease (Matilla et al. <xref ref-type="bibr" rid="CR20">1997</xref>; Chen et al. <xref ref-type="bibr" rid="CR5">2008</xref>). However, the precise role of Lanp in neuronal survival is still unclear. Furthermore, while its interaction with Rb prevents cell death (Adegbola and Pasternack <xref ref-type="bibr" rid="CR1">2005</xref>), studies in proliferating cells indicate that Lanp can also be involved in apoptosis (Jiang et al. <xref ref-type="bibr" rid="CR9">2003</xref>; Pan et al. <xref ref-type="bibr" rid="CR25">2009</xref>).</p>
      <p>Our earlier studies demonstrate that Rb plays a central role in the neuroprotective functions of CXCL12/CXCR4 (Khan et al. <xref ref-type="bibr" rid="CR14">2008</xref>). Given the reported interaction of Lanp and Rb in non-neuronal cells (Adegbola and Pasternack <xref ref-type="bibr" rid="CR1">2005</xref>), we asked whether they may also interact in neurons supporting their survival. Here, we examined the constitutive and CXCL12-stimulated expression of endogenous Lanp in primary neuronal cultures at different stages of differentiation, its interaction with Rb, and the effect of Lanp overexpression on excitotoxicity. Our data show for the first time a protective role of this nuclear Rb partner in postmitotic neurons.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials and methods</title>
      <p><bold>Neuronal cultures</bold> Cortical neurons were obtained from the brains of 17-day-old rat fetuses and cultured in a serum-free medium using the bilaminar cell culture system (Banker and Cowan <xref ref-type="bibr" rid="CR3">1977</xref>; Kaech and Banker <xref ref-type="bibr" rid="CR10">2006</xref>), in which pure neuronal cultures are grown in the presence of a separate glial feeder layer supporting their growth and differentiation. This model reproduces, to a certain extent, the in vivo environment (i.e., the presence of neuronal and non-neuronal cells) and offers the major advantage that neurons can be separated from the glia at any time in order to analyze neuron-specific biological responses. We have extensively used the bilaminar culture system to study expression and function of chemokine receptors in neurons, including CXCR4, and previously demonstrated that the signaling pathways induced by direct activation of neuronal CXCR4 promote neuronal survival mechanisms, even in the absence of glia (Khan et al. <xref ref-type="bibr" rid="CR12">2004</xref>; Sengupta et al. <xref ref-type="bibr" rid="CR29">2009</xref>). In these studies, unless otherwise noted, CXCL12 treatments (20&#xA0;nM) were performed in the presence of glia in order to predict the potential outcome of CXCL12 stimulation in vivo. Neurons were always separated from the glia immediately before protein extraction. Cortical neurons were plated on poly-<sc>l</sc>-lysine-coated 15-mm coverslips (40&#x2009;&#xD7;&#x2009;10<sup>3</sup> or 50&#x2009;&#xD7;&#x2009;10<sup>3</sup> cells) or 60-mm dishes (1&#x2009;&#xD7;&#x2009;10<sup>6</sup> cells)&#x2014;depending on the type of experiment. Treatments started after at least 7&#xA0;days in vitro (7 DIV).</p>
      <p><bold>Immunocytochemistry</bold> Neurons were fixed in 4% paraformaldehyde. For neuronal marker staining, anti-&#x3B2; tubulin III (clone TUJ1, 1:500, from Covance, Berkeley, CA, USA) was used, followed by a cy3-conjugated (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>) or a cy2-conjugated secondary antibody (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>). For Lanp staining, anti-Lanp (C-18, 1:200, Santa Cruz Biotechnology, Santa Cruz, CA, USA) was followed by a biotin-conjugated secondary antibody and then by cy3-streptavidin. To visualize FLAG-Lanp-expressing neurons (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>), a DYKDDDDK Tag antibody that detects FLAG (cat# 2368, 1:800, Cell Signaling Technology, Danvers, MA, USA) was used followed by a cy3-conjugated secondary antibody (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>). Nuclear staining was obtained using Hoechst 33342 (0.5&#xA0;&#x3BC;l/ml). Cells were observed under an epifluorescent microscope (Olympus IX70, Melville, NY, USA) connected to a CCD camera (Micromax, Trenton, NJ, USA), and images were taken using Metamorph software (Molecular Devices, Sunnyvale, CA, USA).
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Expression of Lanp in primary cortical neurons: Neurons were cultured for 1&#x2013;30&#xA0;days as reported in the methods section, then fixed and stained for endogenous Lanp (<italic>green</italic>) using a specific antibody. The neuronal marker &#x3B2; tubulin III (<italic>red</italic>) was used for visualization of neuronal cell bodies while the nuclei were stained with Hoechst 33342 (<italic>blue</italic>). <italic>Scale bar</italic> = 50&#xA0;&#x3BC;m</p></caption><graphic xlink:href="11481_2010_9228_Fig1_HTML" id="MO1"/></fig></p>
      <p><bold>Western blots</bold> For total cell lysates, neurons were scraped in lysis buffer (25&#xA0;mM Tris, 150&#xA0;mM NaCl, 5&#xA0;mM NaF, 1&#xA0;mM EDTA, 1&#xA0;mM DTT, 1% IGEPAL-CA-630, 5&#xA0;mg each of aprotinin, leupeptin, and pepstatin, 1&#xA0;mM AEBSF, and 1&#xA0;mM vanadate), as reported previously (Shimizu et al. <xref ref-type="bibr" rid="CR32">2007</xref>; Khan et al. <xref ref-type="bibr" rid="CR14">2008</xref>). The protein concentration of cell lysates was determined using the bicinchoninic acid assay from Pierce (Rockford, IL, USA). Equal amounts of proteins (25&#xA0;&#x3BC;g) were loaded in each lane, separated by SDS-PAGE and transferred to PVDF membranes for immunoblotting. The following primary antibodies were used: anti-Lanp (C-18, 1:1,000; Santa Cruz Biotechnology), anti-Rb (1:4,000,G3-245; BD Biosciences PharMingen, Franklin Lakes, NJ, USA), and anti-Actin (1:5,000, A2066; Sigma-Aldrich, St. Louis, MO, USA). Bands were detected by chemiluminescence using the Pierce SuperSignal West Femto maximum sensitivity kit, according to the manufacturer's instructions, and analyzed using the FluorChem 8900 apparatus from Alpha Innotech (San Leandro, CA, USA).</p>
      <p><bold>Immunoprecipitation</bold> For immunoprecipation (IP), 250&#xA0;&#x3BC;g protein was used for each treatment (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). IP reactions were performed with goat anti-Lanp or monoclonal anti-Rb antibodies and ExactaCruz&#x2122; B (sc-45039), or ExactaCruz&#x2122; A reagents (sc-45038, Santa Cruz Biotechnology), respectively, were used, according to the manufacturer's protocols. The precipitated extracts were immunoblotted and probed for Lanp and Rb proteins as described above.</p>
      <p><bold>Survival assays and transfections</bold> For survival assays, rat cortical neurons (50 &#xD7; 10<sup>3</sup> cells per coverslip) were divided in two groups. One group was transfected with pFLAG-Lanp vector (expressing murine Lanp; a gift from Dr. Huda Zoghby, Baylor College of Medicine, Houston, TX, USA), whereas the other group was transfected with a control plasmid expressing GFP; the Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) was used for transfection (4&#xA0;&#x3BC;g of plasmid per coverslip). NMDA neurotoxicity assay was conducted as described before (Khan et al. <xref ref-type="bibr" rid="CR14">2008</xref>); only the cells expressing GFP and those positive to FLAG immunostaining were counted (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). Transfection efficiency in these experiments was about 35%.</p>
      <p><bold>Materials</bold> Unless otherwise specified, tissue culture media are from Invitrogen. CXCL12 (SDF-1&#x3B1;) was purchased from PeproTech (Rocky Hill, NJ, USA); the chemokine was reconstituted in PBS/0.1% BSA, stored as stock solution at &#x2212;20&#xB0;C, and used at a final concentration of 20&#xA0;nM. AMD3100 was obtained from Sigma-Aldrich, reconstituted in water, and used at final concentrations of 100&#xA0;ng/ml.</p>
      <p><bold>Statistical analysis</bold> Student's <italic>t</italic> test or ANOVA (followed by Newman&#x2013;Keuls multiple comparison test) were used for statistical analysis (<italic>P</italic>&#x2009;&lt;&#x2009;0.05 was considered statistically significant). All data are reported as mean &#xB1; SEM. Experiments were performed at least three times.</p>
    </sec>
    <sec id="Sec3">
      <title>Results</title>
      <p><bold>Expression of Lanp protein in cortical neurons and its regulation by the chemokine CXCL12</bold> Recent ex vivo studies have shown that Lanp is expressed predominantly in the neuronal nuclei in distinct regions of the brain (Kovacech et al. <xref ref-type="bibr" rid="CR15">2007</xref>). However, earlier studies in neuronal cell lines have suggested the possibility of subcellular translocation (i.e., from nucleus to cytosol) of Lanp upon differentiation (Opal et al. <xref ref-type="bibr" rid="CR24">2003</xref>). In order to determine intracellular localization of Lanp in primary neuronal cultures, immunostaining of Lanp was performed on rat cortical neurons cultured for up to 4&#xA0;weeks (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). At all the time periods studied (from 1 to 30&#xA0;days), Lanp was found to be expressed mainly in the neuronal nuclei, and no increase in the cytosolic levels of the protein was observed upon neuronal differentiation and maturation at any time (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Thus, Lanp expression in our primary cultures reflects the in vivo situation; these data also suggest that the expression of the protein in neuronal cell lines may be altered and/or influenced by the cell cycle.Our previous studies indicate that CXCR4 is able to control Rb transcriptional activity (Khan et al. <xref ref-type="bibr" rid="CR14">2008</xref>). We have shown that RNAi-mediated Rb depletion in cortical neurons leads to the disruption of CXCR4-mediated protection against neurotoxicity (Khan et al. <xref ref-type="bibr" rid="CR14">2008</xref>). Lanp is known to interact with Rb, and this interaction is implicated in the regulation of cell survival in different cell lines (Adegbola and Pasternack <xref ref-type="bibr" rid="CR1">2005</xref>). To determine whether the CXCL12/CXCR4 axis can also regulate Lanp protein levels, differentiated rat cortical neurons were treated with CXCL12 (20&#xA0;nM for 30&#xA0;min) and protein extracts collected after 3&#x2013;5&#xA0;h&#x2014;in analogy to our studies with Rb. Western blot analysis showed an increase in the endogenous Lanp protein in treated neurons (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>). Pre-treatment with the CXCR4-antagonist, AMD3100 (100&#xA0;ng/ml, added to the culture medium before CXCL12), abolished the up-regulation of Lanp by CXCR4, confirming the involvement of CXCR4 activity in this effect (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>). Overall, these data indicate that CXCR4 stimulation regulates Lanp in cortical neurons.
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>CXCL12 increases endogenous Lanp levels in cortical neurons: Rat cortical neurons were treated with CXCL12 (20&#xA0;nM) for 30&#xA0;min; total cell extracts were collected at 3&#x2013;5&#xA0;h after treatment and immunoblotted for Lanp and actin (<bold>a</bold>). Equal amounts of protein (25&#xA0;&#x3BC;g) were loaded in each lane. Densitometric analysis of three independent experiments is reported in the graph (<bold>A</bold>) as mean&#xB1;SEM of band density units (<italic>asterisk</italic>, <italic>P</italic>&#x2009;&lt;&#x2009;0.05 vs control; <italic>n</italic>&#x2009;=&#x2009;3). The immunoblots on the bottom (<bold>B</bold>) are from additional studies with neurons treated with the specific CXCR4 antagonist, AMD 3100 (100&#xA0;ng/ml). AMD was added to the culture 15&#xA0;min before exposure to CXCL12 (20&#xA0;nM, 5&#xA0;h); at the end of the treatment, total cell lysates were extracted and immunoblotted for Lanp and actin. The graph (<bold>B</bold>) represents the densitometric analysis of three independent experiments (<italic>asterisk</italic>, <italic>P</italic>&#x2009;&lt;&#x2009;0.05 vs CXCL12)</p></caption><graphic xlink:href="11481_2010_9228_Fig2_HTML" id="MO2"/></fig></p>
      <p><bold>Interaction of Lanp with Rb and its involvement in CXCL12 neuroprotection</bold> In order to determine whether Lanp interacts with Rb in neurons, IP studies were performed in cortical neuronal extracts using specific antibodies against Lanp or Rb. Immunoprecipitates were then probed by Western blots for both of these proteins individually (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). These experiments indicate that endogenous Rb and Lanp co-immunoprecipitate, suggesting that they constitutively interact in neurons (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). Next, we asked whether Lanp may be involved in the CXCL12 neuroprotective effect along with Rb; based on our previous studies concerning the regulation of Rb by CXCL12 and its consequences on neuronal survival (Khan et al. <xref ref-type="bibr" rid="CR14">2008</xref>), we predicted that CXCL12 would be able to up-regulate Lanp levels in control, as well as NMDA-treated, neurons. To test this hypothesis, neurons were treated with CXCL12 and/or NMDA (100&#xA0;&#x3BC;M for 20&#xA0;min) as we previously reported (Khan et al. <xref ref-type="bibr" rid="CR14">2008</xref>). Cell extracts were collected after 5&#xA0;h, immunoblotted, and probed for Lanp. As expected, CXCL12 was able to increase Lanp protein levels in both control and NMDA-treated neurons (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>).
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Endogenous Lanp interacts with Rb in neurons: Equal amounts of neuronal extracts (250&#xA0;&#x3BC;g; 9DIV) were incubated with either anti-Rb or anti-Lanp before electrophoresis/immunoblotting for both Rb and Lanp. A specific IgG mixture was used as immunoprecipitation control</p></caption><graphic xlink:href="11481_2010_9228_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Effect of CXCL12 and NMDA on neuronal Lanp: Vehicle- or CXCL12-treated neurons were stimulated with NMDA (100&#xA0;&#x3BC;M for 20&#xA0;min); neuronal extracts were collected after 5&#xA0;h and immunobotted for Lanp and actin. Densitometric analysis of three independent experiments is reported in the graph as mean&#xB1;SEM of band density units (<italic>asterisk</italic>, <italic>P</italic>&#x2009;&lt;&#x2009;0.05 vs NMDA; <italic>n</italic>&#x2009;=&#x2009;3)</p></caption><graphic xlink:href="11481_2010_9228_Fig4_HTML" id="MO4"/></fig></p>
      <p><bold>Role of Lanp in neuroprotection against NMDA exitotoxicity</bold> To study the role of Lanp in neuronal survival, we used a Lanp expression vector (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>), in which the Lanp sequence is fused with FLAG tag at N-terminal (Matilla et al. <xref ref-type="bibr" rid="CR20">1997</xref>). Expression of this vector in primary cortical neurons led to Lanp localization to the nucleus similar to endogenous Lanp (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>). Moreover, Flag&#x2013;Lanp did not affect cell survival under basal conditions (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5b</xref>), in contrast to findings in proliferating cells (Jiang et al. <xref ref-type="bibr" rid="CR9">2003</xref>; Pan et al. <xref ref-type="bibr" rid="CR25">2009</xref>). To explore if Lanp could protect neurons from excitotoxicity, neurons transfected with the same vector were treated with NMDA (100&#xA0;&#x3BC;M for 20&#xA0;min) and neuronal death assessed 24&#xA0;h later; a set of control neurons transfected with a GFP expression vector that underwent the same NMDA treatment was used for comparison. In our previously published studies, this NMDA protocol has shown to induce 60% to 70% neuronal death (Patel et al. <xref ref-type="bibr" rid="CR26">2006</xref>). As opposed to NMDA-treated GFP-expressing cells, Lanp-expressing cells were significantly protected from NMDA neurotoxicity (<italic>P</italic>&#x2009;&lt;&#x2009;0.001). This is the first evidence of a protective role of Lanp in neurons.
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Overexpression of Lanp protects neurons from NMDA toxicity: Neurons were transfected with a Flag&#x2013;Lanp expression vector (pFlagLanp). The exogenous Lanp was visualized by anti-FLAG antibody (<bold>a</bold>). Cells were also stained for a neuronal marker, &#x3B2; tubulin III (<italic>green</italic>) and Hoechst 33342 to visualize nuclei (<italic>blue</italic>). <italic>Scale bar</italic> = 50&#xA0;&#x3BC;m. Neurons transfected either with control pGFP vector or pLanp vector were treated with NMDA (100&#xA0;&#x3BC;M, 20&#xA0;min) and fixed after 24&#xA0;h to determine cell survival. FLAG&#x2013;LANP-expressing neurons were visualized by immunocytochemistry and data collected from three independent experiments is expressed as mean&#xB1;SEM in the graph (<bold>b</bold>). <italic>Asterisk</italic>, <italic>P</italic> vs NMDA (pLanp) &lt;0.001</p></caption><graphic xlink:href="11481_2010_9228_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Discussion</title>
      <p>This report lends support to the role of CXCL12/CXCR4 axis in the control of neuronal survival and adds Lanp to the list of modulators of gene expression that are regulated by CXCR4. Furthermore, our data suggest that Lanp might be involved in CXCL12/CXCR4 neuroprotection from excitotoxicity (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>). Lanp belongs to a family of evolutionarily conserved proteins that have leucine-rich repeats in their N-termini (Matilla and Radrizzani. <xref ref-type="bibr" rid="CR19">2005</xref>). These motifs are involved in its interaction with a variety of other proteins, and these interactions determine the range of its functions in a specific cell type. Its acidic C-terminus contains the nuclear localization signal (Pan et al. <xref ref-type="bibr" rid="CR25">2009</xref>).
<fig id="Fig6"><label>Fig.&#xA0;6</label><caption><p>A schematic diagram showing the CXCL12/CXCR4-mediated signaling events leading to the putative formation of Lanp-Rb gene repressor complex and its effect on neuronal survival</p></caption><graphic xlink:href="11481_2010_9228_Fig6_HTML" id="MO6"/></fig></p>
      <p>In this report, we observe that, in primary cortical neurons, native Lanp is expressed predominantly and abundantly in the nucleus throughout neuronal differentiation. Thus, the subcellular translocation of Lanp as shown by an earlier study in a differentiating neuronal cell line seems to be limited to that specific cell line, since all other evidence, including this paper, argues against it being a common mechanism in CNS (Opal et al. <xref ref-type="bibr" rid="CR24">2003</xref>; Kovacech et al. <xref ref-type="bibr" rid="CR15">2007</xref>). Interestingly, previous studies in proliferating cells have shown that cytosolic Lanp is involved in pathways that affect cell survival. For example, cytosolic Lanp is involved in granzyme A-induced death of cytotoxic T-lymphocyte target cells, or, in other cells, it is a part of a specific complex that promotes formation and function of apoptosome resulting in caspase-mediated cell death (Fan et al. <xref ref-type="bibr" rid="CR7">2003</xref>; Jiang et al. <xref ref-type="bibr" rid="CR9">2003</xref>; Pan et al. <xref ref-type="bibr" rid="CR25">2009</xref>). On the contrary, in postmitotic neurons, Lanp is primarily expressed in the nucleus, can interact with other endogenous nuclear proteins, such as Rb, and promote neuronal survival. Lanp is an essential part of the INHAT complex and, as a result, it is involved in binding to and, thus, masking the N-terminal histone tails from histone acetyl transferase activity (Seo et al. <xref ref-type="bibr" rid="CR30">2001</xref>; Seo et al. <xref ref-type="bibr" rid="CR31">2002</xref>). Hence, Lanp acts mainly as a gene repressor. Recent studies in neuronal cells indicate that Lanp interacts with a transcriptional repressor, E4F, and enhances its activity, further supporting the nuclear role for Lanp in neurons (Cvetanovic et al. <xref ref-type="bibr" rid="CR6">2007</xref>). Moreover, in the context of neurodegenerative disorders, the mutated ataxin-1, which has been implicated in spinocerebellar ataxia type 1 (SCA1), is able to relieve Lanp-E4F gene repression by competing with Lanp for binding to E4F; these interactions might lead to SCA1 neuropatholgy in cerebellum (Cvetanovic et al. <xref ref-type="bibr" rid="CR6">2007</xref>). The present study shows that the chemokine CXCL12 positively regulates neuronal Lanp. Considering the interaction of endogenous Lanp with Rb, these data suggest that Lanp might be involved in CXCR4-regulated Rb signaling in neurons. Our previous studies implicate Rb and Rb-mediated gene repression in the neuroprotection action of CXCL12 (Khan et al. <xref ref-type="bibr" rid="CR14">2008</xref>). Novel data also show that CXCL12 reduces in vitro/in vivo expression of specific neuronal genes, namely, the NR2B subunit of NMDA receptor, normally controlled by HDAC/Rb-dependent mechanisms (Nicolai et al. <xref ref-type="bibr" rid="CR23">2010</xref>; Qiu and Ghosh <xref ref-type="bibr" rid="CR28">2008</xref>). As a result of the limited expression of NR2B, CXCL12 would be able to control calcium entry via extrasynaptic NMDA receptor, thus preventing excitotoxicity (Nicolai et al. <xref ref-type="bibr" rid="CR23">2010</xref>). The findings reported in the present paper suggest that Lanp might be one of the Rb-interacting proteins involved in neuronal survival in response to NMDA insult.</p>
      <p>In agreement with this conclusion, when Lanp is overexpressed in cortical neurons, it retains its nuclear localization and protects neurons against NMDA toxicity. Overall, these results suggest that Lanp acts as an Rb-interacting protein in neurons and may play a significant role in neuronal survival in vivo. These data are in line with other reports showing that Lanp regulates the promoter of the neurofilament light chain (NF-L) gene through inhibition of histone acetylation, and it is thus implicated in neurite outgrowth (Kular et al. <xref ref-type="bibr" rid="CR16">2009</xref>). Interestingly, CXCR4 stimulation leads to comparable effects during CNS development and differentiation (Pujol et al. <xref ref-type="bibr" rid="CR27">2005</xref>). It is possible that Lanp mediates some of these effects. Unfortunately, we were unable to provide direct evidence about this in the present study as depletion of Lanp in these neurons by shRNA resulted in major alterations of neuronal differentiation, in agreement with and in addition to the previous studies (Kular et al. <xref ref-type="bibr" rid="CR16">2009</xref>; Suppl. Figs.&#xA0;<xref rid="MO7" ref-type="">1</xref> and <xref rid="MO8" ref-type="">2</xref>). Thus, NMDA-induced neurotoxicity was negligible in these cultures (not shown). Further investigations using conditional knockout of Lanp or alternative approaches may be necessary to address this issue.</p>
      <p>In conclusion, our results show that CXCL12 positively regulates nuclear expression of Lanp, which may act in concert with Rb to ultimately reduce excitotoxicity (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>). Although further studies are required to determine the molecular mechanisms involved in the regulation of Lanp by CXCR4 and its direct link to neuroprotection, our data raise the possibility that Lanp, along with Rb, contributes to suppression of specific genes that play a critical role in neuronal survival and differentiation.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <sec id="AppESM1">
        <title>Electronic supplementary material</title>
        <supplementary-material id="d28e741" content-type="local-data">
          <p>Below is the link to the electronic supplementary material.
</p>
          <media id="MO7" xlink:href="11481_2010_9228_Fig7_ESM.gif">
            <label>Figure S1</label>
            <caption>
              <p>Depletion of Lanp protein by RNAi in primary rat cortical neurons: Neurons were transfected just before plating with an shLanp or a control plasmid (6&#xA0;&#x3BC;g/10<sup>6</sup> cells), both expressing green fluorescent protein (GFP), using Amaxa nucleofection. After 9&#xA0;days in vitro, neurons were collected and processed for Western blot (30&#xA0;&#x3BC;g protein/lane) as reported in the methods and shown here (<italic>top</italic>); examples of neurons transfected in the same way with shRNA-GFP, immunostained for endogenous Lanp (<italic>red</italic>), and counterstained for nuclear marker using Hoechst 33342 (<italic>blue</italic>) are shown in the bottom micrographs (GIF 53&#xA0;kb)</p>
            </caption>
          </media>
          <media xlink:href="11481_2010_9228_MOESM1_ESM.tif" id="MOESM1" mimetype="image" mime-subtype="tiff">
            <label>Figure S1</label>
            <caption>
              <p>High-resolution image file (TIFF 1047&#xA0;kb)</p>
            </caption>
          </media>
          <media id="MO8" xlink:href="11481_2010_9228_Fig8_ESM.gif">
            <label>Figure S2</label>
            <caption>
              <p>Morphological changes in Lanp-deficient cortical neurons: Neurons were transfected with control or shLanp plasmid (Kular et al. <xref ref-type="bibr" rid="CR16">2009</xref>), using Amaxa nucleofection (6&#xA0;&#x3BC;g/10<sup>6</sup> cells); both vectors express GFP. These cells were fixed after 9&#xA0;days of growth in vitro, immunostained for the neuronal marker MAP2 (<italic>red</italic>) and nuclear dye Hoechst 33342 (<italic>blue</italic>). Marked alterations in neurite outgrowth were observed in Lanp-depleted neurons (GIF 190&#xA0;kb)</p>
            </caption>
          </media>
          <media xlink:href="11481_2010_9228_MOESM2_ESM.tif" id="MOESM2" mimetype="image" mime-subtype="tiff">
            <label>Figure S2</label>
            <caption>
              <p>High-resolution image file (TIFF 3825&#xA0;kb)</p>
            </caption>
          </media>
        </supplementary-material>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p><bold>Conflicts of interest</bold> The authors declare no conflicts of interest.</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adegbola</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Pasternack</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Phosphorylated retinoblastoma protein complexes with pp 32 and inhibits pp32-mediated apoptosis</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>15497</fpage>
          <lpage>15502</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M411382200</pub-id>
          <pub-id pub-id-type="pmid">15716273</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bachis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Biggio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Major</surname>
              <given-names>EO</given-names>
            </name>
            <name>
              <surname>Mocchetti</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>M- and T-tropic HIVs promote apoptotis of rat neurons</article-title>
          <source>J Neuroimmune Pharmacol</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>150</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="doi">10.1007/s11481-008-9141-3</pub-id>
          <pub-id pub-id-type="pmid">19034668</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banker</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Cowan</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>Rat hippocampal neurons in dispersed cell culture</article-title>
          <source>Brain Res</source>
          <year>1977</year>
          <volume>126</volume>
          <fpage>397</fpage>
          <lpage>425</lpage>
          <pub-id pub-id-type="doi">10.1016/0006-8993(77)90594-7</pub-id>
          <pub-id pub-id-type="pmid">861729</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Becker</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Bonni</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cell cycle regulation of neuronal apoptosis in development and disease</article-title>
          <source>Prog Neurobiol</source>
          <year>2004</year>
          <volume>72</volume>
          <fpage>1</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pneurobio.2003.12.005</pub-id>
          <pub-id pub-id-type="pmid">15019174</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Grundke-Iqbal</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Iqbal</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>I1PP2A affects tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A</article-title>
          <source>J Biol Chem</source>
          <year>2008</year>
          <volume>283</volume>
          <fpage>10513</fpage>
          <lpage>10521</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M709852200</pub-id>
          <pub-id pub-id-type="pmid">18245083</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cvetanovic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rooney</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Toporovskaya</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Zoghbi</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Opal</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The role of LANP and ataxin 1 in E4F-mediated transcriptional repression</article-title>
          <source>EMBO Rep</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>671</fpage>
          <lpage>677</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.embor.7400983</pub-id>
          <pub-id pub-id-type="pmid">17557114</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fan</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Beresford</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lieberman</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor</article-title>
          <source>Cell</source>
          <year>2003</year>
          <volume>112</volume>
          <fpage>659</fpage>
          <lpage>672</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(03)00150-8</pub-id>
          <pub-id pub-id-type="pmid">12628186</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR8">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guyon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nahon</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity</article-title>
          <source>J Mol Endocrinol</source>
          <year>2007</year>
          <volume>38</volume>
          <fpage>365</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="doi">10.1677/JME-06-0013</pub-id>
          <pub-id pub-id-type="pmid">17339399</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kofron</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Donnelly</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>299</volume>
          <fpage>223</fpage>
          <lpage>226</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1076807</pub-id>
          <pub-id pub-id-type="pmid">12522243</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaech</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Banker</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Culturing hippocampal neurons</article-title>
          <source>Nat Protoc</source>
          <year>2006</year>
          <volume>1</volume>
          <fpage>2406</fpage>
          <lpage>2415</lpage>
          <pub-id pub-id-type="doi">10.1038/nprot.2006.356</pub-id>
          <pub-id pub-id-type="pmid">17406484</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR11">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Brandimarti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Musser</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Resue</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Fatatis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Meucci</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>The chemokine receptor CXCR4 regulates cell-cycle proteins in neurons</article-title>
          <source>J Neurovirol</source>
          <year>2003</year>
          <volume>9</volume>
          <fpage>300</fpage>
          <lpage>314</lpage>
          <pub-id pub-id-type="pmid">12775414</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR12">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Brandimarti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Huynh</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Fatatis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Meucci</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis</article-title>
          <source>AIDS Res Hum Retroviruses</source>
          <year>2004</year>
          <volume>20</volume>
          <fpage>1063</fpage>
          <lpage>1071</lpage>
          <pub-id pub-id-type="doi">10.1089/aid.2004.20.1063</pub-id>
          <pub-id pub-id-type="pmid">15585097</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR13">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Le</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Mullen-Przeworski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brandimarti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fatatis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Meucci</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Regulation of neuronal P53 activity by CXCR 4</article-title>
          <source>Mol Cell Neurosci</source>
          <year>2005</year>
          <volume>30</volume>
          <fpage>58</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1016/j.mcn.2005.05.007</pub-id>
          <pub-id pub-id-type="pmid">16005638</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR14">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Brandimarti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nicolai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Crowe</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Meucci</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein</article-title>
          <source>Cell Death Differ</source>
          <year>2008</year>
          <volume>15</volume>
          <fpage>1663</fpage>
          <lpage>1672</lpage>
          <pub-id pub-id-type="doi">10.1038/cdd.2008.95</pub-id>
          <pub-id pub-id-type="pmid">18583990</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR15">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kovacech</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kontsekova</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zilka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Novak</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Skrabana</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Filipcik</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Iqbal</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Novak</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A novel monoclonal antibody DC63 reveals that inhibitor 1 of protein phosphatase 2A is preferentially nuclearly localised in human brain</article-title>
          <source>FEBS Lett</source>
          <year>2007</year>
          <volume>581</volume>
          <fpage>617</fpage>
          <lpage>622</lpage>
          <pub-id pub-id-type="doi">10.1016/j.febslet.2007.01.015</pub-id>
          <pub-id pub-id-type="pmid">17266954</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR16">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kular</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Cvetanovic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Siferd</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kini</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Opal</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Neuronal differentiation is regulated by leucine-rich acidic nuclear protein (LANP), a member of the inhibitor of histone acetyltransferase complex</article-title>
          <source>J Biol Chem</source>
          <year>2009</year>
          <volume>284</volume>
          <fpage>7783</fpage>
          <lpage>7792</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M806150200</pub-id>
          <pub-id pub-id-type="pmid">19136565</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR17">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ransohoff</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology</article-title>
          <source>Prog Neurobiol</source>
          <year>2008</year>
          <volume>84</volume>
          <fpage>116</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pneurobio.2007.11.003</pub-id>
          <pub-id pub-id-type="pmid">18177992</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR18">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macaluso</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Montanari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Giordano</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes</article-title>
          <source>Oncogene</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>5263</fpage>
          <lpage>5267</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1209680</pub-id>
          <pub-id pub-id-type="pmid">16936746</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR19">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matilla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Radrizzani</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The Anp32 family of proteins containing leucine-rich repeats</article-title>
          <source>Cerebellum</source>
          <year>2005</year>
          <volume>4</volume>
          <fpage>7</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.1080/14734220410019020</pub-id>
          <pub-id pub-id-type="pmid">15895553</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR20">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matilla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koshy</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Isobe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Orr</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Zoghbi</surname>
              <given-names>HY</given-names>
            </name>
          </person-group>
          <article-title>The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>389</volume>
          <fpage>974</fpage>
          <lpage>978</lpage>
          <pub-id pub-id-type="doi">10.1038/40159</pub-id>
          <pub-id pub-id-type="pmid">9353121</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR21">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuoka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Taoka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Satozawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ichimura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yamakuni</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Isobe</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1994</year>
          <volume>91</volume>
          <fpage>9670</fpage>
          <lpage>9674</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.91.21.9670</pub-id>
          <pub-id pub-id-type="pmid">7937870</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR22">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Dyson</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Retinoblastoma protein partners</article-title>
          <source>Adv Cancer Res</source>
          <year>2001</year>
          <volume>82</volume>
          <fpage>1</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.1016/S0065-230X(01)82001-7</pub-id>
          <pub-id pub-id-type="pmid">11447760</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR23">
        <mixed-citation publication-type="other">Nicolai J. Burbassi S, Rubin J, Meucci O (2010) CXCL12 inhibits expression of the NMDA receptor's NR2B subunit through a histone deacetylase-dependent pathway contributing to neuronal survival. Cell Death and Disease 1, e33 (1 April 2010) doi:10.1038/cddis.2010.10</mixed-citation>
      </ref>
      <ref id="CR24">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Opal</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Propst</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Matilla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Orr</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Zoghbi</surname>
              <given-names>HY</given-names>
            </name>
          </person-group>
          <article-title>Mapmodulin/leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesis</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>34691</fpage>
          <lpage>34699</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M302785200</pub-id>
          <pub-id pub-id-type="pmid">12807913</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR25">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pan</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Graca</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Shao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>PHAPI/pp 32 suppresses tumorigenesis by stimulating apoptosis</article-title>
          <source>J Biol Chem</source>
          <year>2009</year>
          <volume>284</volume>
          <fpage>6946</fpage>
          <lpage>6954</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M805801200</pub-id>
          <pub-id pub-id-type="pmid">19121999</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR26">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patel</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Sengupta</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bardi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Mullen-Przeworski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Meucci</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Modulation of neuronal CXCR4 by the micro-opioid agonist DAMGO</article-title>
          <source>J Neurovirol</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>492</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="doi">10.1080/13550280601064798</pub-id>
          <pub-id pub-id-type="pmid">17162664</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR27">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pujol</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kitabgi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Boudin</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons</article-title>
          <source>J Cell Sci</source>
          <year>2005</year>
          <volume>118</volume>
          <fpage>1071</fpage>
          <lpage>1080</lpage>
          <pub-id pub-id-type="doi">10.1242/jcs.01694</pub-id>
          <pub-id pub-id-type="pmid">15731012</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR28">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qiu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression</article-title>
          <source>Neuron</source>
          <year>2008</year>
          <volume>60</volume>
          <fpage>775</fpage>
          <lpage>787</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2008.09.040</pub-id>
          <pub-id pub-id-type="pmid">19081374</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR29">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sengupta</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Burbassi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cappello</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vallee</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Meucci</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons</article-title>
          <source>J Neurosci</source>
          <year>2009</year>
          <volume>29</volume>
          <fpage>2534</fpage>
          <lpage>2544</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5865-08.2009</pub-id>
          <pub-id pub-id-type="pmid">19244528</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR30">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seo</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>McNamara</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Heo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lane</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Chakravarti</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein</article-title>
          <source>Cell</source>
          <year>2001</year>
          <volume>104</volume>
          <fpage>119</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00196-9</pub-id>
          <pub-id pub-id-type="pmid">11163245</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR31">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seo</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Macfarlan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>McNamara</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mukai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Heo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chakravarti</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Regulation of histone acetylation and transcription by nuclear protein pp 32, a subunit of the INHAT complex</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>14005</fpage>
          <lpage>14010</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M112455200</pub-id>
          <pub-id pub-id-type="pmid">11830591</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR32">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimizu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Hippensteel</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Parkar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Raghupathi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Meucci</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology</article-title>
          <source>Neurobiol Dis</source>
          <year>2007</year>
          <volume>25</volume>
          <fpage>17</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nbd.2006.08.004</pub-id>
          <pub-id pub-id-type="pmid">17011204</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p>Support: NIH-NIDA (R01-DA15014 and R01-DA19808 to OM)</p>
      </fn>
    </fn-group>
  </back>
</article>
